LifeStance Health valued at more than $7 bln in U.S. IPO
June 10 (Reuters) - LifeStance Health Group Inc’s shares jumped over 11% in their Nasdaq debut on Thursday, giving the therapy provider a market value of nearly $7.5 billion and underscoring demand for mental health services during the COVID-19 pandemic.
The company’s stock, backed by an affiliate of buyout firm TPG, opened at $20, compared to the initial public offering price of $18 set on Wednesday. (Reporting by Noor Zainab Hussain in Bengaluru; Editing by Shailesh Kuber)
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.